We can readily understand why investors are attracted to unprofitable companies. For example, although...
Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. AIM ImmunoTech Inc (NYSE: AIM ) was the worst decliner of the week, as ...
Millendo Therapeutics to Present at Upcoming Investor Conferences
We can readily understand why investors are attracted to unprofitable companies. For example, although...
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings level the playing field for ordinary investors. The latest round of 13F filings disclosed the […]
As of late, it has definitely been a great time to be an investor in Millendo Therapeutics.
Millendo Therapeutics Reports Full Year 2019 Operating and Financial Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 2) Dova Pharmaceuticals Inc (NASDAQ: DOVA ) Down In The ...
Although Millendo Therapeutics is a newer player in the biotech public market and the PWS market is small, it represents a so-far unmet need, Chico said in the note. About 10,000 patients suffer from PWS in the US, and there are no treatments available for the hallmark syndrome, hyperphagia, the analyst mentioned.
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September 30th. In this article, we look at what those funds think of Millendo Therapeutics, Inc. (NASDAQ:MLND) based on that […]
Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)
Millendo Therapeutics Reports First Quarter 2020 Operating and Financial Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Dec. 4) Allakos Inc (NASDAQ: ALLK )(announced exploration of ...